Stay in the loop

Sign up today to get the latest around plaque psoriasis, VTAMA (tapinarof) cream, 1%, and other helpful tips and information.

*Required field

First Name

Please enter a first name

Last Name

Please enter a last name

ZIP Code

Please enter a valid ZIP code

Email

Please enter a valid email

By entering my email I agree to allow Dermavant Sciences, Inc., and companies working on its behalf, to use this information to contact me about health and product-related information and services associated with plaque psoriasis and other products.

By submitting this form, I agree to the Privacy Policy and Terms of Use.

Thanks for signing up! Before you go…

Would you mind answering some additional questions for us?

This will help us tailor your VTAMA cream experience specifically to you!

1. What best describes your plaque psoriasis treatment journey?

Although diagnosed, I haven’t tried a prescription treatment yet.

Unhappy. Still trying to find something out there for me.

My current treatment is OK. Not great, but good enough.

I’m happy, but open to learning more about VTAMA cream.

I have not been diagnosed but suspect I may have plaque psoriasis.

2. Are you currently using VTAMA cream?

No, my dermatologist has not prescribed it.

No, it's been prescribed, but I haven't filled my prescription.

No, I have used it in the past, but I no longer use it.

Yes, I use it daily, exactly as my dermatologist prescribed.

Yes, I use it, but not regularly.

3. How involved are you in treatment decisions related to your plaque psoriasis?

I rely solely on my dermatologist. What he/she says, goes.

It’s an equal partnership. We make these decisions together.

I listen to my dermatologist. But I will ask questions before we move forward.

I usually go to my visits with requests for treatments I’ve researched.

I have not yet had a conversation about plaque psoriasis.

*Required field

First Name

Please enter a first name

Last Name

Please enter a last name

ZIP Code

Please enter a valid ZIP code

Email

Please enter a valid email

By entering my email I agree to allow Dermavant Sciences, Inc., and companies working on its behalf, to use this information to contact me about health and product-related information and services associated with plaque psoriasis and other products.

By submitting this form, I agree to the Privacy Policy and Terms of Use.

*Required field

First Name

Please enter a first name

Last Name

Please enter a last name

ZIP Code

Please enter a valid ZIP code

Email

Please enter a valid email

By entering my email I agree to allow Dermavant Sciences, Inc., and companies working on its behalf, to use this information to contact me about health and product-related information and services associated with plaque psoriasis and other products.

By submitting this form, I agree to the Privacy Policy and Terms of Use.

*Required field

First Name

Please enter a first name

Last Name

Please enter a last name

ZIP Code

Please enter a valid ZIP code

Email

Please enter a valid email

By entering my email I agree to allow Dermavant Sciences, Inc., and companies working on its behalf, to use this information to contact me about health and product-related information and services associated with plaque psoriasis and other products.

By submitting this form, I agree to the Privacy Policy and Terms of Use.

*Required field

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Manage Consent Preferences

Strictly Necessary Cookies	Always active
Performance Cookies
Targeting Cookies

Individual patient results:

You are now leaving this site

Click Continue below to leave the current site and be taken to a site maintained by a third party who is solely responsible for its content. Dermavant is providing this link to you only as a convenience; its inclusion does not imply the endorsement of the linked site by Dermavant.

Did you find what you were looking for?

Make sure to sign up for more education on plaque psoriasis and VTAMA cream before you leave the site.

Are you sure?

The contents of this site are intended for US Healthcare Professionals (HCP). Please certify that you are an HCP by clicking the appropriate link below.

You’re on your way

Thank you for signing up. You’ll be hearing from us soon.

Have more questions? Chat live with a nurse.

Email sent!

PopHeader ×

Popup

PopFooter

VTAMA^® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

No thanks, take me to the VTAMA cream website
for adults with plaque psoriasis

US-VTMA-2400316

VTAMA^® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

No thanks, take me to the VTAMA
cream website for adults with plaque psoriasis

the topical treatment of plaque psoriasis in adults.
the topical treatment of atopic dermatitis in adults and pediatric patients 2 years of age and older.

Adverse Events: In plaque psoriasis, the most common adverse reactions (incidence ≥1%) were: red raised bumps around the hair pores (folliculitis), pain or swelling in the nose and throat (nasopharyngitis), skin rash or irritation, including itching and redness, peeling, burning, or stinging (contact dermatitis), headache, itching (pruritus), and flu (influenza).

Adverse Events: In atopic dermatitis, the most common adverse reactions (incidence ≥1%) were: upper respiratory tract infection, red raised bumps around the hair pores (folliculitis), lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and stomach-area (abdominal) pain.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Sitemap

1. What best describes your plaque psoriasis treatment journey?

2. Are you currently using VTAMA cream?

3. How involved are you in treatment decisions related to your plaque psoriasis?

Manage Consent Preferences

VTAMA® (tapinarof) cream, 1% is now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA® (tapinarof) cream, 1% is now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA® (tapinarof) cream, 1% is now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA® (tapinarof) cream, 1% is now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA^® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA^® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA^® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.

VTAMA^® (tapinarof) cream, 1% is
now approved to treat eczema (atopic dermatitis) in adults and children down to 2 years of age.